8-KFiled Aug 10, 8:00 PM ET

Adagio Medical Reports Quarter Ended June 30, 2026 Results

$ADGM · Adagio Medical Holdings, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Adagio Medical Reports Quarter Ended June 30, 2026 Results

What Happened

  • Adagio Medical Holdings, Inc. announced on August 11, 2026 that it issued a press release reporting its financial results and business update for the quarter ended June 30, 2026. The press release is furnished as Exhibit 99.1 to the Form 8‑K and the filing is reported under Item 2.02 (Results of Operations and Financial Condition).

Key Details

  • Filing date: August 11, 2026; reporting period: quarter ended June 30, 2026.
  • The company furnished a press release (Exhibit 99.1) containing the financial results and business update.
  • The Form 8‑K discloses results of operations and financial condition (Item 2.02); no other material items (e.g., executive changes or transactions) were reported in this filing.

Why It Matters

  • This 8‑K provides investors with the company’s latest quarterly results and business status—key inputs for assessing earnings, revenue trends, cash position and near‑term outlook.
  • Retail investors should read the attached press release (Exhibit 99.1) for the specific financial figures and any operational updates that could affect valuation or near‑term trading.